Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 16;10(10):e039447.
doi: 10.1136/bmjopen-2020-039447.

Internet-based patient- primary care physician-cardiologist integrated management model of hypertension in China: study protocol for a multicentre randomised controlled trial

Runyu Ye #  1 , Rufeng Shi #  1 , Kai Liu  1 , Xin Zhang  1 , Si Wang  1 , Hang Liao  1 , Xinran Li  1 , Qiling Gou  1 , Xi Rong  1 , Zhipeng Zhang  1 , Changqiang Yang  1 , Xiangyu Yang  1 , Xiaoping Chen  2
Affiliations

Internet-based patient- primary care physician-cardiologist integrated management model of hypertension in China: study protocol for a multicentre randomised controlled trial

Runyu Ye et al. BMJ Open. .

Abstract

Introduction: The control rate of hypertension is low in China, especially in rural, western and minority areas. This is related to poor medical skills among physicians in primary care institutions and low levels of trust among patients. However, primary healthcare institutions are the main battleground for the prevention and treatment of hypertension. It is worth exploring how to most effectively integrate patients, primary care physicians and cardiologists in tertiary hospitals, to build a long-term mechanism for the prevention and treatment of hypertension. In this study, we aim to evaluate the clinical effectiveness and conduct a health economic evaluation of an internet-based patient-primary care physician-cardiologist integrated management model of hypertension in areas of China with different socioeconomic levels.

Methods and analysis: This is a 12-month, multicentre, randomised controlled trial involving patients with hypertension in urban communities and rural areas of Sichuan Province, China. Each primary healthcare institution will cooperate with their tertiary hospital through the Red Shine Chronic Disease Management System (RSCDMS). Patients will be randomly assigned 1:1 to two groups: (1) a traditional care group; (2) an intervention group in which primary care physicians and cardiologists can share patient data and manage patients together through the RSCDMS. Patients can upload their blood pressure (BP) values and communicate with physicians using the system. The primary outcome is the change in systolic BP over a 12-month period. Secondary outcomes are changes in diastolic BP, BP control rate, values of 24-hour ambulatory BP monitoring, difference in cost-effectiveness between the groups, patient satisfaction, medication adherence and home BP monitoring compliance. All data will be recorded and stored in the RSCDMS and analysed using IBM SPSS V.26.0.

Ethics and dissemination: This study has been approved by the Biomedical Research Ethics Committee of the West China Hospital of Sichuan University in Sichuan, China (No. 2020-148). Written informed consent will be obtained from all participants. The results of this study will be disseminated to the public through academic conferences and peer-reviewed journals.

Trial registration number: ChiCTR2000030677.

Keywords: hypertension; primary care; telemedicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study design and flow diagram.
Figure 2
Figure 2
Function of the Red Shine Chronic Disease Management System. ABPM, 24-hour ambulatory blood pressure monitoring.
Figure 3
Figure 3
The screenshot for the module of the patients.
Figure 4
Figure 4
The screenshot for the website of the physicians.
See this image and copyright information in PMC

References

    1. Wang Z, Chen Z, Zhang L, et al. . Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation 2018;137:2344–56. 10.1161/CIRCULATIONAHA.117.032380 - DOI - PubMed
    1. Revision Committee of guidelines on the management of hypertension in China. 2018 Chinese guidelines for the management of hypertension. ZhongGuo Xin Xue Guan Za Zhi 2019;24:24–56.
    1. Lu J, Lu Y, Wang X, et al. . Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China peace million persons project). Lancet 2017;390:2549–58. 10.1016/S0140-6736(17)32478-9 - DOI - PubMed
    1. Staessen JA, Wang JG, Thijs L, et al. . Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305–15. 10.1016/S0140-6736(01)06411-X - DOI - PubMed
    1. Staessen JA, Gasowski J, Wang JG, et al. . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865–72. 10.1016/S0140-6736(99)07330-4 - DOI - PubMed

Publication types